What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Antidepressant
His main research concerns Antidepressant, Endocrinology, Internal medicine, Pharmacology and Behavioural despair test.
The Antidepressant study combines topics in areas such as Receptor and Fluoxetine.
His Endocrinology research incorporates themes from Brain-derived neurotrophic factor and 5-HT receptor.
His work carried out in the field of Internal medicine brings together such families of science as PI3K/AKT/mTOR pathway and Phenelzine.
His research investigates the connection with Pharmacology and areas like Agonist which intersect with concerns in Mianserin and Anxiolytic.
His Behavioural despair test course of study focuses on Serotonin and Neurotransmitter, Anesthesia and Drug.
His most cited work include:
- Assessing antidepressant activity in rodents: recent developments and future needs (1326 citations)
- Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. (1214 citations)
- The spectrum of behaviors influenced by serotonin (930 citations)
What are the main themes of his work throughout his whole career to date?
Irwin Lucki mainly focuses on Internal medicine, Endocrinology, Pharmacology, Serotonin and Antidepressant.
His Internal medicine research incorporates elements of Anesthesia and Tail suspension test.
Irwin Lucki has included themes like Agonist, Receptor and 5-HT receptor in his Endocrinology study.
His Pharmacology study integrates concerns from other disciplines, such as Serotonin uptake, Dopamine receptor D2, Monoamine neurotransmitter, Partial agonist and Serotonin reuptake inhibitor.
His Serotonin research is multidisciplinary, incorporating perspectives in Neuroscience and Neurotransmitter.
His Antidepressant study frequently intersects with other fields, such as Fluoxetine.
He most often published in these fields:
- Internal medicine (59.05%)
- Endocrinology (57.62%)
- Pharmacology (36.19%)
What were the highlights of his more recent work (between 2010-2020)?
- Internal medicine (59.05%)
- Endocrinology (57.62%)
- Antidepressant (29.52%)
In recent papers he was focusing on the following fields of study:
Irwin Lucki focuses on Internal medicine, Endocrinology, Antidepressant, Buprenorphine and Pharmacology.
His work on Fluoxetine, Social defeat, Serotonin reuptake inhibitor and Dopamine as part of general Internal medicine research is often related to Synaptopodin, thus linking different fields of science.
His Antidepressant research includes themes of Major depressive disorder, Neuroplasticity, Neurotransmitter and Serotonin.
In his study, Serotonin Uptake Inhibitors, Animal studies and Serotonergic is inextricably linked to 5-HT receptor, which falls within the broad field of Neurotransmitter.
His Buprenorphine study also includes fields such as
- κ-opioid receptor together with Desipramine,
- Treatment-resistant depression which intersects with area such as Toxicology,
- Naltrexone that connect with fields like Mood and Anti-Anxiety Agents.
He combines subjects such as NMDA receptor, Receptor, Serine racemase, Agonist and Metabotropic glutamate receptor 2 with his study of Pharmacology.
Between 2010 and 2020, his most popular works were:
- Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. (186 citations)
- High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. (170 citations)
- The role of serotonin receptor subtypes in treating depression: a review of animal studies. (162 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Dopamine
- Neurotransmitter
His primary areas of investigation include Antidepressant, Pharmacology, Endocrinology, Internal medicine and Neuroscience.
In Antidepressant, he works on issues like Serotonin, which are connected to Anxiolytic.
His studies deal with areas such as Buprenorphine, Receptor, κ-opioid receptor and Desipramine as well as Pharmacology.
As part of his studies on Endocrinology, he frequently links adjacent subjects like Real-time polymerase chain reaction.
In the field of Internal medicine, his study on Dopamine transporter, Glucocorticoid receptor and Corticosterone overlaps with subjects such as 3,4-Dihydroxyphenylacetic acid.
His Behavioural despair test study combines topics from a wide range of disciplines, such as NMDA receptor, Psychotomimetic, Ketamine, Major depressive disorder and Hallucinogen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
